An Efficacy and Outcome Study of Supplemental Oxygen Treatment in Patients With Suspected Myocardial Infarction
Status:
Completed
Trial end date:
2016-12-30
Target enrollment:
Participant gender:
Summary
The use of supplemental oxygen in the setting of suspected acute myocardial infarction (AMI)
is manifested in international treatment guidelines and established in prehospital and
hospital clinical routine throughout the world.
However, to date there is no conclusive evidence from adequately designed and powered trials
supporting this practice. Existing data is conflicting and failing to clarify the role of
supplemental oxygen in AMI.
The DETO2X-AMI trial is designed to shed light on this important issue.
Phase:
Phase 3
Details
Lead Sponsor:
Karolinska Institutet
Collaborators:
Swedish Foundation for Strategic Research Swedish Heart Lung Foundation The Swedish Research Council